CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
Yesterday the BHP Group Ltd (ASX:BHP) share price dropped 4% after shares in the mining powerhouse went ‘ ex-dividend’.
The S&P/ASX 200 (INDEXASX:XJO)(^AXJO) is expected to open higher today, the USA’s S&P 500 Index (.INX) rose 0.45% on Thursday.
CSL Limited (ASX:CSL) is now the 5th largest Biotechnology company in the world according to their ASX Announcement released yesterday.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.62% at lunch.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently down 0.81% at lunch.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.48% at lunch.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently down 1.30% at lunch.
CSL Limited (ASX:CSL) shares fell 3% Wednesday morning despite a promising update.
Here are the stories from the S&P/ASX 200 (INDEXASX:XJO)(^AXJO) and Australian finance circles today.
